Regulon

Regulon: R-3017

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
133.66394119Pr-11Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9235 ENSG00000008517 IL32 P24001
602 ENSG00000069399 BCL3 P20749
6347 ENSG00000108691 CCL2 P13500
6364 ENSG00000115009 CCL20 P78556
54210 ENSG00000124731 TREM1 K7EKM5
27180 ENSG00000129450 SIGLEC9 Q9Y336
11098 ENSG00000150687 PRSS23 O95084
4837 ENSG00000166741 NNMT P40261
6036 ENSG00000169385 RNASE2 P10153
1263 ENSG00000173846 PLK3 Q9H4B4
1806 ENSG00000188641 DPYD Q12882
3426 ENSG00000205403 CFI P05156
10537 ENSG00000231968 UBD O15205

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
NANGIBOTIDETREM1ProteinINHIBITORTriggering receptor expressed on myeloid cells 1 inhibitor20
CARLUMABCCL2AntibodyINHIBITORC-C motif chemokine 2 inhibitor20
ENILURACILDPYDSmall moleculeINHIBITORDihydropyrimidine dehydrogenase inhibitor30
GIMERACILDPYDSmall moleculeINHIBITORDihydropyrimidine dehydrogenase inhibitor30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3017

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-01973PCDH9down-regulatesELF4activatesR-3017205Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-03008SPEF2down-regulatesELF4activatesR-3017201Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-06051OTOAdown-regulatesELF4activatesR-3017202Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-06091FGFR3up-regulatesELF4activatesR-3017202Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-07028ATRXdown-regulatesELF4activatesR-30172011Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-07334NOD2up-regulatesELF4activatesR-30172010Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-08116PLEKHG4Bdown-regulatesELF4activatesR-3017202Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-09276RP1down-regulatesELF4activatesR-3017208Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-10998BMP5down-regulatesELF4activatesR-3017206Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-15682DCHS2up-regulatesELF4activatesR-3017204Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-15858ZNF845down-regulatesELF4activatesR-3017202Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-18891INPP5Jdown-regulatesELF4activatesR-3017205Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-19485NF1up-regulatesELF4activatesR-30172014Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-20229GPR15up-regulatesELF4activatesR-3017203Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-21064KRTAP4-7up-regulatesELF4activatesR-3017208Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-21697MUC17up-regulatesELF4activatesR-3017209Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-22757IDH1down-regulatesELF4activatesR-30172011Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-23083PDHA2down-regulatesELF4activatesR-3017202Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL

CMF-29393PTCHD3down-regulatesELF4activatesR-3017204Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

NANGIBOTIDE, CARLUMAB, ENILURACIL, GIMERACIL